Essex Bio-Technology (HKSE:01061) 3-Year Book Growth Rate : 7.50% (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology 3-Year Book Growth Rate?

Essex Bio-Technology's Book Value per Share for the quarter that ended in Dec. 2024 was HK$3.75.

During the past 12 months, Essex Bio-Technology's average Book Value per Share Growth Rate was 10.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 7.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 11.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Essex Bio-Technology was 59.60% per year. The lowest was -11.70% per year. And the median was 23.00% per year.

Competitive Comparison of Essex Bio-Technology's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Essex Bio-Technology's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Essex Bio-Technology 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Essex Bio-Technology (HKSE:01061) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Essex Bio-Technology 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Essex Bio-Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN

Website

http://www.essexbio.com

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Executives

Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin	2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines